Valuation Ind-Swift Laboratories Limited

Stocks

Market Closed - NSE India S.E. 14:05:08 28/10/2026 +03			5-day change	1st Jan Change
378.95 ^INR	+2.75%		+10.64%	+329.89%

10-05	Ind-Swift Laboratories Limited Approves Appointment of Amit Mathur as Independent Director	CI
09-17	Ind-Swift Laboratories Limited announced that it has received INR 343 million in funding from Essix Biosciences Limited	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	4,251	3,938	3,262	5,918	4,961	11,397
Change	-	-7.37%	-17.18%	81.43%	-16.17%	129.72%
Enterprise Value (EV) ¹	14,189	13,254	11,701	1,764	695.5	7,184
Change	-	-6.59%	-11.72%	-84.92%	-60.59%	932.99%
P/E	-135x	-183x	6.85x	1.41x	2.38x	26.1x
PBR	0.7x	0.66x	0.48x	0.64x	0.49x	0.82x
PEG	-	5.8x	-0x	0x	-0x	-0.3x
Capitalization / Revenue	0.47x	0.37x	0.27x	0.46x	0.88x	1.76x
EV / Revenue	1.56x	1.26x	0.96x	0.14x	0.12x	1.11x
EV / EBITDA	8.54x	5.96x	4.9x	0.66x	-3.19x	16.1x
EV / EBIT	12.8x	14.3x	6.45x	0.82x	-1.59x	43.9x
EV / FCF	58x	49.3x	26.6x	0.18x	-0.33x	-5.29x
FCF Yield	1.72%	2.03%	3.76%	558%	-302%	-18.9%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.5326	-0.3637	8.055	71.24	35.21	5.03
Distribution rate	-	-	-	-	-	-
Net sales ¹	9,068	10,521	12,159	12,973	5,617	6,491
EBITDA ¹	1,661	2,224	2,389	2,683	-217.8	445.2
EBIT ¹	1,110	924.1	1,815	2,150	-438.6	163.7
Net income ¹	-31.47	-21.49	476	4,210	2,505	431.2
Net Debt ¹	9,938	9,315	8,439	-4,153	-4,265	-4,212
Reference price ²	71.95	66.65	55.20	100.15	83.96	131.43
Nbr of stocks (in thousands)	59,087	59,087	59,087	59,087	59,087	86,712
Announcement Date	9/7/21 A	9/7/22 A	9/5/23 A	9/6/24 A	9/5/25 A	9/5/26 A

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IND-SWIFT LABORATORIES LIMITED	-	-	-	-	338M
ELI LILLY AND COMPANY	37.66x	13.18x	27.98x	0.53%	1,143B
JOHNSON & JOHNSON	39.33x	6.61x	18.6x	1.99%	647B
ABBVIE INC.	37.45x	8.4x	17.37x	2.4%	506B
ROCHE HOLDING AG	21.46x	5.22x	12.98x	2.51%	384B
MERCK & CO., INC.	103.38x	5.8x	24.86x	2.4%	350B
NOVARTIS AG	21.99x	5.69x	13.69x	2.94%	293B
ASTRAZENECA PLC	22.31x	4.51x	12.87x	1.96%	265B
AMGEN INC.	28.42x	7.28x	13.03x	2.25%	242B
GILEAD SCIENCES, INC.	-45.78x	7.1x	27.53x	2.07%	197B
Average	29.58x	7.09x	18.77x	2.12%	402.79B
Weighted average by Cap.	35.27x	8.35x	20.48x	1.8%